ANNUALAWARD MEETING OF THE C.E.ALKEN PRIZEWINNERS MUNIICH. Host: Ferdinand Eisenberger. November 30th through December 2nd,2000
|
|
- Dwayne Williamson
- 5 years ago
- Views:
Transcription
1 ANNUALAWARD MEETING OF THE C.E.ALKEN PRIZEWINNERS MUNIICH November 30th through December 2nd,2000 Host: Ferdinand Eisenberger
2 9:00 lst Session: 9:10-9:30 Invited lecture 9:35-9:45 9:50-10:00 Welcome Eisenbergeq F. Prostute cüncer (part 1) The challenge ofradical prostatectomy: the effects oftechnique on outcomes Scardino, P T. Influence ofcell cycle associated proteins on the development of prostate carcinoma Machtens, 5., Kuczyk, M. A., Stief, C. G., Jonas, [1. Angiogenic assessment of tumor aggressiveness in prostate cancer Jaege4 T. M., Siegsmund, M., Rabe, J., Grobholz, R., Jünemann, K. P. Alken. P. 10:05-10:15 Restoration of the cadherin-catenin pathway in an alpha-catenin negative prostate cancer cell line leads to complete reorganization of cell structure - a model of tensegrity Paul, R., Ewing, C. M., Coffey, D. C., Isaacs, W B. 10:20-10:35 2nd Session: Coffee break Operative Urology (part 1) 10:35-10:55 Invited lecture 11:00 11:10 Balanitis xerotica obliterans - a plastic surgeon's experience Bracka, A. Cytoreductive surgery for recurrent renal cell carcinoma Stief, C. G., Matuschek, E., Jonas, U. 11:15-1l:25 I I : :40 Omentum majus in operative urology Krilble, T. Repair of ureteral defects with single and double reconfigured colonic segments Ubrig, 8., Waldner M., Eggersmann, C., Roth, S. ilwlsir*r#**:ls$]]r*5.inil
3 ll:45-12:05 Laterally extended endopelvic resection (LEER) - indications and techniques Invited lecture Höckel, M., Hohenfellnet R. 12:30-14:00 Lunch 3rd Session: Prostate cancer (part 2) 14:00-14:10 Perineal complications after perineal prostatectomy Fichtner J., Gillitzer R., Thüroff, J' W 14:15-14:25 Surgical margins after radical prostatectomy for prostate cancer Dimitrijevic, D-, Eisenberge4 F 4th Session: Bludder cüncer 14:30-14:40 A biological approach to inhibit implantation of bladder cancef Böhle, A., Jurczok, A., Wulf,7., Ardelt' P', Brandau, S'' Jocham' D' 14:45-14:55 Brachytherapy for bladder cancer - an update Kurth. K. H', vdveen, H., Reisman, C' 15:00-15:10 chemotherapy of bladder cancer: experience with new drugs Müller' S' C., Steiner G., Perabo, F' Alken, P 15:15-15:25 Photodynamic diagnosis (PDD) of bladder cancer is it useful? van Moorselaar R. J. 15:30-15:50 Coffee break 5th Session: Operutive Urology (part 2) l5:50-16:00 The pelvic plexus and antireflux surgery - topographical considerations and clinical consequences LeilSnea J., Allhoff, E. P, Hohenfellner R' 16:05-16:15 Value of cytoreductive tumornephrectomy for metastatic RCC in the era of modern immunotherapy Mickisch, G' H. J. ;iryiwj@triffiltffi i*
4 16:20-16:30 Long term results oftrigone-sparing substitution enterocystoplasty for interstitial cystitis (IC) in woman van Ophoven,4., Hertle, L. 6th Session Miscellaneous (pürt 1) 16:35-16:,45 Videomicroscopic imaging of pyelo-ureteral peristalsis in rats during simultaneous cystometry Tillig,8., Constantinou, C. E. 16:50-17:00 Evaluation of asyrnptomatic gross hematuria in patients receiving warfarin or platelet aggregation inhibitors Schulze, H., Ludas, R. 17:05-11:15 Analysis of urological tumours using genomic assay technology Tanke, H. J. 311]{SrEUllllRlug*llll*1u#ry,]**
5 Presentution of the C. E. ALKEN PRIZE 9:00 Award presentation Thüroff, J.W 9:15-9:35 A standardized model for in vivo investigations of anticholinergic effects on bladder function, salivation and electromyographic characteristics of the detrusor Award lecture Scheepe, J. R., Braun, P M., Bross, S', Jünemann, K' P', Alken' P 9:40-10:00 Sacral root stimulation for bladder evacuation in dogs: selective rootlet neurotomy and local hyperthermia Award lecture Dahms, 5., Muschek, M., Piechota, H.-J., Gleason, C' A', Hohenfellner, M., Thnagho, E. A. 7th Session: Miscelluneous (purt 2) 10:05-10:15 Virtual cystoscopy with MRI for the diagnosis of bladder tumors Steiner G., Alken, P, Müller S. C. 10:20-10:30 Men's health research in Germany Eickenberg, H.-U. 10:35 - l0:45 Atrionatriuretic peptide in prevention and treatment of acute renal failure: experimental results and review of the literature Humke. U., Gebhard, T. 10:50 - I l:00 Growth failure revisited - a second look at the metabolic consequences of urinary diversion.in childhood Gerharz. 8.. Woodhouse, C. 11:05-11:30 Coffee break \th Session: Neurourology / Incontinence 11:30-1l:40 Stress incontinence in the animal model - can histological investigations reveal functional changes? Sievert. K. D., Dahms, 5., Lue, T.E ]]r#ffiii:ffiffilnr*c
6 1 1 : :55 Some new observations on the central effects of urinary bladder neuromodulation Blok, B. 9th Session: Benign prostütic hyperplasia 12:00-12:10 The IPSS does not correlate with pressure flow data of urodynamically obstructive BPH-patients, but pressure flow data have a predictive value on treatment outcome Danuser, H., Studer U. E. 12:15-12:25 DHT induced prostate growth and its restrain with Tadenan Constantinou, C. E. 10th Session: Kidnev cancer 12:30-12:40 Expression of the human telomerase reverse transcriptase is not related to telomerase activity in normal and malignant renal tissue Rohde, V, Wullich, 8., Humke, U. 12:45-12:55 Oxygen consumption in renal cell cancer and benign renal parenchyma Otto,7., Suhr J., Rübben, H. 13:00 Farewell Lunch stnnnrsiffitn8{srlr*$*4*9]]ni]]
ANNUAL AWARD MEETING OF THE C.E. ALKEN PRIZE WINNERS
ANNUAL AWARD MEETING OF THE C.E. ALKEN PRIZE WINNERS STUTTGART November 30 th through December 2 nd, 2006 Host: Ulrich Humke Scientific Meeting Friday, December 1 st, 2006 09.00 Welcome U. Humke 09.15
More information4 th Year Urology Core Objectives Keith Rourke (Revised June 1, 2007)
4 th Year Urology Core Objectives Keith Rourke (Revised June 1, 2007) I. Genitourinary Trauma: 1. Goal: The student will be able to demonstrate a basic clinical approach to the management & diagnosis of
More informationProstate Overview Quiz
Prostate Overview Quiz 1. The path report reads: Gleason 3 + 4 = 7. The Gleason s score is a. 3 b. 4 c. 7 d. None of the above 2. The path report reads: Moderately differentiated adenocarcinoma of the
More informationUrology An introduction to cut up DR J R GOEPEL
Urology An introduction to cut up DR J R GOEPEL Overview Principles Individual organs Small pieces Partial resections Whole organs Data recording and data sets Principles You are working for the patient
More informationIndex. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Ablation, of prostate, holmium laser, 485 495 African prune tree (Pygeum africanum), 454 455 Alfuzosin, 445 446 Alpha-adrenergic agonists,
More informationFriday 25 May EAU Lecture Where are we in male infertility in 2018? J.O.R. Sonksen, Herlev (DK)
Friday 25 May 2018 08.45 09.00 Welcome M. Jievaltas, Kaunas (LT) A. Kotsar, Tartu (EE) A. Strotsky, Minsk (BY) C.R. Chapple, Sheffield (GB) 09.00 09.30 EAU Lecture Where are we in male infertility in 2018?
More information1 st Kuwait Urology Board Research Day Schedule April 19 th Keynote Speaker
Keynote Speaker Session Start End Welcome Address 08:00 08:15 Session A: Original Research Posters #1-12 Tour (5 mins per poster) Original Research Oral Presentations for Posters #1-12 08:15 09:15 09:15
More informationcreatinine lab order placed abdomen, MRI abdomen, ultrasound abdomen ordered or performed
Non-QPP Measures # Measure Title Definition Type Domain 1 Cryptorchidism: Inappropriate use of scrotal/groin ultrasound on boys Percentage of patients (boys) =< 18 years of age newly diagnosed with undescended
More informationMUSCLE-INVASIVE AND METASTATIC BLADDER CANCER
MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER (Text update March 2008) A. Stenzl (chairman), N.C. Cowan, M. De Santis, G. Jakse, M. Kuczyk, A.S. Merseburger, M.J. Ribal, A. Sherif, J.A. Witjes Introduction
More informationProstate Case Scenario 1
Prostate Case Scenario 1 H&P 5/12/16: A 57-year-old Hispanic male presents with frequency of micturition, urinary urgency, and hesitancy associated with a weak stream. Over the past several weeks, he has
More informationTHURSDAY, DECEMBER 13, 2018
THURSDAY, DECEMBER 13, 2018 7:00 am Welcome and Introduction 7:10 am The Hans E. Shapira Lecture Prostate Cancer: A Perspective; the Right Treatment for the Right Patient at the Right Time Peter Scardino,
More informationNon-QPP Measures. # Measure Title Definition Type Domain. Cryptorchidism: Inappropriate use of scrotal/groin ultrasound on boys
Non-QPP Measures # Measure Title Definition Type Domain 1 Cryptorchidism: Inappropriate use of scrotal/groin ultrasound on boys Percentage of patients (boys) =< 18 years of age newly diagnosed with undescended
More informationHong Kong College of Surgical Nursing
Hong Kong College of Surgical Nursing Higher Surgical Nursing Training: Part B Specialty - Urological Nursing Curriculum TABLE OF CONTENTS No. Contents Page. Introduction. Aims. Learning Objectives 4.
More informationMUSCLE - INVASIVE AND METASTATIC BLADDER CANCER
10 MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER Recommendations from the EAU Working Party on Muscle Invasive and Metastatic Bladder Cancer G. Jakse (chairman), F. Algaba, S. Fossa, A. Stenzl, C. Sternberg
More informationNeuroanatomy, Neurophysiology and Clinical Presentation of Visceral Urological Pain
Neuroanatomy, Neurophysiology and Clinical Presentation of Visceral Urological Pain Prof Dr K. Everaert Functional urology Department of Urology Ghent University Hospital Gent, Belgium Chronic pelvic pain
More informationPRACTICAL Urology. USC Institute of Urology 4 th Annual Conference: Guest Faculty. Thursday January 31, January 31, February 1 2, 2019
USC Institute of Urology 4 th Annual Conference: PRACTICAL Urology January 31, February 1 2, 2019 Guest Faculty Jeffrey Cadeddu, MD University of Texas Southwestern University of Michigan University of
More informationSubject Index. Androgen antiandrogen therapy, see Hormone ablation therapy, prostate cancer synthesis and metabolism 49
OOOOOOOOOOOOOOOOOOOOOOOOOOOOOO Subject Index Androgen antiandrogen therapy, see Hormone ablation therapy, synthesis and metabolism 49 Bacillus Calmette-Guérin adjunct therapy with transurethral resection
More informationNeuromodulationöSacral, Peripheral and Central: Current Status, Indications, Results and New Developments
EAU Update Series EAU Update Series 2 (2004) 187 194 NeuromodulationöSacral, Peripheral and Central: Current Status, Indications, Results and New Developments Peter Martin Braun*, Christoph Seif, Christof
More informationTHURSDAY, DECEMBER 13, 2018
THURSDAY, DECEMBER 13, 2018 7:00-7:10am 7:10-7:15am 7:15-7:45am Welcome and Introduction Audience Response Question with App Orientation Ketan K. Badani, MD The Hans E. Shapira Lecture Prostate Cancer:
More informationAdvanced Pelvic Malignancy: Defining Resectability Be Aggressive. Lloyd A. Mack September 19, 2015
Advanced Pelvic Malignancy: Defining Resectability Be Aggressive Lloyd A. Mack September 19, 2015 CONFLICT OF INTEREST DECLARATION I have no conflicts of interest Advanced Pelvic Malignancies Locally Advanced
More informationThe Royal Marsden. Prostate case study. Presented by Mr Alan Thompson Consultant Urological Surgeon
Prostate case study Presented by Mr Alan Thompson Consultant Urological Surgeon 2 Part one Initial presentation A 62 year old male solicitor attends your GP surgery. He has rarely seen you over the last
More informationPercentage of patients who underwent endoscopic procedures following SWL
Non-QPP Measures Measure ID Measure Title Definition Type Domain 1 AQUA12 Benign Prostate Hyperplasia: IPSS improvement after diagnosis Percentage of patients with NEW diagnosis of clinically significant
More informationNon-QPP Measures 3 AQUA12. 6 AQUA15 Stones: Urinalysis documented 30 days before
Non-QPP Measures 1 Measure ID Measure Title Definition Type Domain AQUA3 (inverse) Cryptorchidism: Inappropriate use of scrotal/groin ultrasound on boys Percentage of patients (boys) =< 18 years of age
More informationDefinition Prostate cancer
Prostate cancer 61 Definition Prostate cancer is a malignant neoplasm that arises from the prostate gland and the most common form of cancer in men. localized prostate cancer is curable by surgery or radiation
More informationBladder Cancer Guidelines
Bladder Cancer Guidelines Agreed by Urology CSG: October 2011 Review Date: September 2013 Bladder Cancer 1. Referral Guidelines The following patients should be considered as potentially having bladder
More informationWhen to worry, when to test?
Focus on CME at the University of Calgary Prostate Cancer: When to worry, when to test? Bryan J. Donnelly, MSc, MCh, FRCSI, FRCSC Presented at a Canadian College of Family Practitioner s conference (October
More informationInternational London Uropathology Conference 2014
Wednesday 18 June 2014 Pre-Conference Registration, Slide Preview & Multiheader Sessions 18.00-21:00: Registration 18.00-21:00: View slide library cases 18:30-19:20: Multiheader Sessions Coronet Room Multiheader
More informationin Laparoscopy The European Congress of Laparoscopy 2007 Bordeaux, France Palais des Congres
Challenges 2007 in Laparoscopy The European Congress of Laparoscopy 2007 Some of the most prominent Laparoscopic Urological Surgeons will perform innovative live surgery demonstrating the full spectrum
More informationMini-Invasive Treatment in Urological Diseases Dott. Alberto Saita Responsabile Endourologia Istituto Clinico Humanitas - Rozzano
Dipartimento di Urologia Direttore Prof. Giorgio Guazzoni Mini-Invasive Treatment in Urological Diseases Dott. Alberto Saita Responsabile Endourologia Istituto Clinico Humanitas - Rozzano alberto.saita@humanitas.it
More informationManagement of Voiding Dysfunction after Prostate Radiotherapy
Management of Voiding Dysfunction after Prostate Radiotherapy Up to Date Symposium on Uro-Oncology December 7, 2012 Belo Horizonte, Brazil Jaspreet S. Sandhu, MD Department of Surgery/Urology Memorial
More informationMayo Clinic Update in Urology 2017: February 20-24, 2017 Atlantis, Paradise Island Bahamas
Monday, February 20, 2017 7:00 a.m. Registration 7:00 Continental Breakfast 7:45 Introduction/Pretest 8:00 PSA Screening Update: Who, What, When, Where Julio C. Gundian, Jr., M.D. 8:20 MRI Prostate: Imaging
More informationUrological Tumours 1 Kidney tumours 2 Bladder tumours
Urological Tumours 1 Kidney tumours 2 Bladder tumours Tim Bracey SpR Histopathology Derriford Hospital Kidney tumours What are we going to talk about?! Anatomy of urinary tract! Types of kidney tumours!
More informationChapter 18: Glossary
Chapter 18: Glossary Sutter Health Cancer Service Line: Prostate Committee Advanced cancer: When the cancer has spread to other parts of the body (including lymph nodes, bones, or other organs) and is
More informationMANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH
MANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH INTRODUCTION (1) Part of male sexual reproductive organ Size
More informationRadical prostate surgery?
Decipher enables personalized and actionable treatment after surgery Radical prostate surgery? The Decipher Prostate Cancer Classifier can help you and your doctor decide on important next steps in your
More informationSaturday, 13 February 2016
Saturday, 13 February 2016 16.10 16.15 Opening and welcome C.R. Chapple, Sheffield (GB) 16.15 18.00 What is new in urology 1 Chairs: C. R. Chapple, Sheffield (GB) 16.15 16.35 Functional urology C. Gratzke,
More informationOveractive Bladder: Diagnosis and Approaches to Treatment
Overactive Bladder: Diagnosis and Approaches to Treatment A Hidden Condition* Many Many patients self-manage by voiding frequently, reducing fluid intake, and wearing pads Nearly Nearly two-thirds thirds
More informationWhat should we consider before surgery? BPH with bladder dysfunction. Inje University Sanggye Paik Hospital Sung Luck Hee
What should we consider before surgery? BPH with bladder dysfunction Inje University Sanggye Paik Hospital Sung Luck Hee Diagnostic tests in three categories Recommendation: there is evidence to support
More informationProstate Cancer Dashboard
Process Risk Assessment Risk assessment: family history assessment of family history of prostate cancer Best Observed: 97 %1 ; Ideal Benchmark:100% measure P8 2 Process Appropriateness of Care Pre-treatment
More informationBladder Case 1 SURGICAL PATHOLOGY REPORT. Procedure: Cystoscopy, transurethral resection of bladder tumor (TURBT)
Bladder Case 1 February 17, 2007 Specimen (s) received: Bladder Tumor Pre-operative Diagnosis: Bladder Cancer Post operative Diagnosis: Bladder Cancer Procedure: Cystoscopy, transurethral resection of
More informationAsian Urology Residency Course 2017 (AURC 2017)
Organizers: Asian Urology Residency Course 2017 (AURC 2017) Urological Association of Asia, American Urological Association, Hong Kong Urological Association and The Chinese University of Hong Kong in
More informationUreteroscopy Is Indicated in every patient with suspected Upper Tract Urothelial Tumor
Ureteroscopy Is Indicated in every patient with suspected Upper Tract Urothelial Tumor Scott G. Hubosky, MD The Demetrius H. Bagley Jr., MD Associate Professor of Urology Director of Endourology Vice Chair
More informationUrinary Adverse Events after Radiation Therapy for Prostate Cancer
Urinary Adverse Events after Radiation Therapy for Prostate Cancer Sexual Medicine Society of North America Scottsdale, Arizona 2016 Jaspreet S. Sandhu, MD Department of Surgery/Urology Memorial Sloan
More informationGUIDELINES ON URINARY INCONTINENCE
GUIDELINES ON URINARY INCONTINENCE 9 J. Thüroff, (chairman), P. Abrams, J-T. Andersen, W. Artibani, E. Chartier-Kastler, C. Hampel, M. Hohenfellner, T. Tammela, Ph. van Kerrebroeck Introduction The condition
More informationGuidelines for the Management of Bladder Cancer West Midlands Expert Advisory Group for Urological Cancer
Guidelines for the Management of Bladder Cancer West Midlands Expert Advisory Group for Urological Cancer West Midlands Clinical Networks and Clinical Senate Coversheet for Network Expert Advisory Group
More informationContinuing Professional Development
Volume 15.4.1 This Lecture Serties qualifies for 0.5 Informal CPD Learning Hours Continuing Professional Development Pelvic Calcifications By Dr Kristin Grace (DACBR) WHAT IS THAT??? Calcifications in
More informationManagement of LUTS after TURP and MIT
Management of LUTS after TURP and MIT Hong Sup Kim Konkuk University TURP & MIT TURP : Gold standard MIT TUIP TUNA TUMT HIFU LASER Nd:YAG, ILC, HoLRP, KTP LUTS after TURP and MIT Improved : about 70% Persistent
More informationAQUA Registry 2019 Non-QPP Measure Specifications. Denominator Exceptions. IPSS<8 None None Yes Patient Reported Outcome (PRO)
AQUA12 Benign Prostate Hyperplasia: IPSS improvement after diagnosis with NEW diagnosis of clinically significant BPH who had IPSS (international prostate symptoms score) or AUASS (American urological
More informationLaparoscopic Surgery. The Da Vinci Robot. Limits of Laparoscopy. What Robotics Offers. Robotic Urologic Surgery: A New Era in Patient Care
Laparoscopic Surgery Robotic Urologic Surgery: A New Era in Patient Care Laparoscopic technique was introduced in urologic surgery in the 1990s Benefits: Improved recovery time, decreased morbidity Matthew
More informationLower Urinary Tract Symptoms (LUTS) and Nurse-Led Clinics. Sean Diver Urology Advanced Nurse Practitioner candidate Letterkenny University Hospital
Lower Urinary Tract Symptoms (LUTS) and Nurse-Led Clinics Sean Diver Urology Advanced Nurse Practitioner candidate Letterkenny University Hospital 01/02/2018 Lower Urinary Tract Symptoms LUTS - one of
More information[PDF] ALTERNATIVES TO LUPRON FOR PROSTATE CANCER EBOOK
06 March, 2018 [PDF] ALTERNATIVES TO LUPRON FOR PROSTATE CANCER EBOOK Document Filetype: PDF 506.4 KB 0 [PDF] ALTERNATIVES TO LUPRON FOR PROSTATE CANCER EBOOK See information on benefits and safety. We
More informationDefinitions of IC: U.S. perspective. Edward Stanford MD MS FACOG FACS Western Colorado
Definitions of IC: U.S. perspective Edward Stanford MD MS FACOG FACS Western Colorado PURPOSE OF A DEFINITION? Identifies with specificity those patients who are most likely to have the disease. Identifies
More informationApplication Request to Hold an Add-On ICS Educational Course. Yes
Application Request to Hold an Add-On ICS Educational Course Name of ICS Member requesting application: Country in which course is to be held: Proposed City Proposed Dates Proposed Venue Accommodation
More informationA schematic of the rectal probe in contact with the prostate is show in this diagram.
Hello. My name is William Osai. I am a nurse practitioner in the GU Medical Oncology Department at The University of Texas MD Anderson Cancer Center in Houston. Today s presentation is Part 2 of the Overview
More informationIndex. Surg Oncol Clin N Am 14 (2005) Note: Page numbers of article titles are in boldface type.
Surg Oncol Clin N Am 14 (2005) 433 439 Index Note: Page numbers of article titles are in boldface type. A Abdominosacral resection, of recurrent rectal cancer, 202 215 Ablative techniques, image-guided,
More informationThessaloniki September 2015 Macedonia Palace
6 th Panhellenic Scientific Meeting of Urodynamics, Neurolurology & Female Urology Section (UNUFU) Of the Hellenic Urological Association With International Participation Thessaloniki 25-26 September 2015
More informationNOTE: This policy is not effective until April 1, Transurethral Water Vapor Thermal Therapy of the Prostate
NOTE: This policy is not effective until April 1, 2019. Medical Policy Manual Surgery, Policy No. 210 Transurethral Water Vapor Thermal Therapy of the Prostate Next Review: December 2019 Last Review: December
More informationAsian Urology Residents' Course 2018 Program
Date Day 1 Asian Perspective (Lectures & Presentations) Time (hrs) Index Topic Presenter 0800 0830 Registration 0830 0845 0845-1700 Welcome Address(s) and ming: UAA PRESIDENT ASU DIRECTOR JUA PRESIDENT
More informationProstate Cancer: 2010 Guidelines Update
Prostate Cancer: 2010 Guidelines Update James L. Mohler, MD Chair, NCCN Prostate Cancer Panel Associate Director for Translational Research, Professor and Chair, Department of Urology, Roswell Park Cancer
More informationMeasure ID Domain Measure Title Measure Description/Definition Numerator Denominator Denominator Exclusions Denominator Exceptions
n-qpp s ID Domain Title Description/Definition Numerator Denominator Denominator Exclusions Denominator Exceptions Riskadjustment AQUA3 (inverse) Cryptorchidism: Inappropriate use of scrotal/groin ultrasound
More informationWEDNESDAY MARCH 8 th. Prevention of Perineal Trauma. Advanced urodynamic course. Marketing. Room Nursing school. Room TURQUESA 5.
WEDNESDAY MARCH 8 th 08:00h-10:00h TURQUESA 1 TURQUESA 2 TURQUESA 3 TURQUESA 4 TURQUESA 5 TUQUESA 6 Nursing school USP Workshop 5: Demystifying and promoting the adherence of Clean Intermittent Catheterization
More informationMultiple Primary and Histology Site Specific Coding Rules URINARY. FLORIDA CANCER DATA SYSTEM MPH Urinary Site Specific Coding Rules
Multiple Primary and Histology Site Specific Coding Rules URINARY 1 Prerequisites 2 Completion of Multiple Primary and Histology General Coding Rules 3 There are many ways to view the Multiple l Primary/Histology
More informationFRIDAY, DECEMBER 14, 2018
FRIDAY, DECEMBER 14, 2018 7:00 am Day Two Welcome Ash Tewari, MBBS, MCh RADICAL PROSTATECTOMY Panelists: Arul Chinnaiyan, MD, PhD; Douglas Scherr, MD; Prasanna Sooriakumaran, MD, PhD; Ofer Yossepowitch,
More informationAn Undergraduate Syllabus for Urology. Produced on behalf of the British Association of Urological Surgeons. March 2012
An Undergraduate Syllabus for Urology Produced on behalf of the British Association of Urological Surgeons March 2012 Authors H Hashim, P Jones, KJ O Flynn, I Pearce, J Royle, M Shaw, AM Sinclair Correspondence
More informationFRIDAY, DECEMBER 14, 2018
FRIDAY, DECEMBER 14, 2018 7:00-7:10am Day Two Welcome Ash Tewari, MBBS, MCh RADICAL PROSTATECTOMY Panelists: Arul Chinnaiyan, MD, PhD; Douglas Scherr, MD; Prasanna Sooriakumaran, MD, PhD; Ofer Yossepowitch,
More informationNeuromodulation and neurostimulation: overview and future potential
Perspective Neuromodulation and neurostimulation: overview and future potential Emil A. Tanagho Department of Urology, University of California, San Francisco Medical Center, San Francisco, California,
More informationAppendix 4 Urology Care Pathways
Appendix 4 Urology Care Pathways Cancer Care Pathways outline the steps and stages in the patient journey from referral through to diagnostics, staging, treatment, follow up, rehabilitation and if applicable
More information7:40-7:50 Radical Prostatectomy Technique for Preservation of Urinary Continence and The Pagano Suture John Libertino, MD
DAY 2 Friday, September 8 GENERAL SESSION SESSION I RADICAL PROSTATECTOMY Moderators: David Albala, MD, Inderbir Gill, MD 7:00-7:10 Surgical Anatomy of Prostate Atsushi Takenaka, MD 7:10-7:20 Neural Supply
More informationGUIDELINES ON NON-MUSCLE- INVASIVE BLADDER CANCER
GUIDELINES ON NON-MUSCLE- INVASIVE BLADDER CANCER (Limited text update December 21) M. Babjuk, W. Oosterlinck, R. Sylvester, E. Kaasinen, A. Böhle, J. Palou, M. Rouprêt Eur Urol 211 Apr;59(4):584-94 Introduction
More informationKidney, Bladder and Prostate Neoplasia. David Bingham MD
Kidney, Bladder and Prostate Neoplasia David Bingham MD typical malignant cytology of bladder washings 1 benign 2 malignant typical malignant cytology of bladder washings b Bladder tumor Non invasive papillary
More informationH(a)ematuria. FX Keeley Consultant Urologist Bristol Urological Institute
H(a)ematuria FX Keeley Consultant Urologist Bristol Urological Institute From Philadelphia to Bristol, England Southmead Hospital, 1916 Southmead Hospital, 2013 Southmead Hospital, 2014 H(a)ematuria Blood
More informationPROGRAMME DRAFT. September 18 th to 20 th 2008
PROGRAMME DRAFT International Advanced Symposium Laparoscopic Treatment of Urological Pelvic Cancers : Course Directors C.C. Abbou Belgium September 18 th to 20 th 2008 Faculty W. Artibani X. Cathelineau
More informationIncontinence. When I was given this topic in urology to discuss with you today I
Incontinence When I was given this topic in urology to discuss with you today I was slightly disappointed. I personally see mostly men for problems such as stones, benign prostatic hyperplasia, prostate
More informationUNM SRMC UROLOGY CLINICAL PRIVILEGES.
o o o Initial privileges (initial appointment) Renewal of privileges (reappointment) Expansion of privileges (modification) INSTRUCTIONS All new applicants must meet the following requirements as approved
More informationNMIBC. Piotr Jarzemski. Department of Urology Jan Biziel University Hospital Bydgoszcz, Poland
NMIBC Piotr Jarzemski Department of Urology Jan Biziel University Hospital Bydgoszcz, Poland 71 year old male patient was admitted to the Department of Urology First TURBT - 2 months prior to the hospitalisation.
More informationUrological cancers why we need to change. Stakeholder workshop 14 March 2013
Urological cancers why we need to change Stakeholder workshop 14 March 2013 Introduction and welcome Today s event aims to cover: 1. Background, clinical evidence and London Cancer s recommendations Q&As
More informationSome prostatic diseases
Some prostatic diseases Benign Prostatic Hyperplasia (Nodular Hyperplasia) Extremely common Present in a significant number of men by the age of 40 & its frequency rises progressively with age, reaching
More informationSexuality Preserving Cystectomy and Neobladder (SPCN): Functional Results of a Neobladder Anastomosed to the Prostate
European Urology European Urology 43 (2003) 646 650 Sexuality Preserving Cystectomy and Neobladder (SPCN): Functional Results of a Neobladder Anastomosed to the Prostate W. Meinhardt *, S. Horenblas Department
More informationIs renal cryoablation becoming an effective alternative to partial nephrectomy?
Is renal cryoablation becoming an effective alternative to partial nephrectomy? J GARNON 1, G TSOUMAKIDOU 1, H LANG 2, A GANGI 1 1 department of interventional radiology 2 department of urology University
More informationWhat Is Prostate Cancer? Prostate cancer is the development of cancer cells in the prostate gland (a gland that produces fluid for semen).
What Is Prostate Cancer? Prostate cancer is the development of cancer cells in the prostate gland (a gland that produces fluid for semen). It is a very common cancer in men; some cancers grow very slowly,
More informationQ&A. Fabulous Prizes. Collecting Cancer Data: Bladder, Renal Pelvis, and Ureter 5/2/13. NAACCR Webinar Series
Collecting Cancer Data Bladder & Renal Pelvis NAACCR 2012 2013 Webinar Series Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching
More informationBladder replacement in men and women: when and when not? Outline. Continent Diversion History
1 Bladder replacement in men and women: when and when not? Eila C. Skinner, MD Professor of Clinical Urology Keck USC School of Medicine Outline 1) Selection criteria for orthotopic diversion: Tumor-related
More informationPROSTATIC ARTERY EMBOLISATION (PAE) FOR BENIGN PROSTATIC HYPERPLASIA. A Minimally Invasive Innovative Treatment
PROSTATIC ARTERY EMBOLISATION (PAE) FOR BENIGN PROSTATIC HYPERPLASIA A Minimally Invasive Innovative Treatment What is the prostate? The prostate is an accessory organ of the male reproductive system.
More informationNEUROMODULATION FOR UROGYNAECOLOGISTS
NEUROMODULATION FOR UROGYNAECOLOGISTS Introduction The pelvic floor is highly complex structure made up of skeletal and striated muscle, support and suspensory ligaments, fascial coverings and an intricate
More informationL. Alexandre Frigini MD; Aaron Thomas, MD; Veronica Lenge de Rosen, MD
Computed Tomography Urography (CTU) for Evaluation of Asymptomatic microscopic hematuria. Is intravenous contrast administration warranted for all patients? A retrospective evaluation utilizing ACR s Appropriateness
More informationA patient with recurrent bladder cancer presents with the following history:
MP/H Quiz A patient with recurrent bladder cancer presents with the following history: 9/23/06 TURB 1/12/07 TURB 4/1/07 TURB 7/12/07 TURB 11/14/07 Non-invasive papillary transitional cell carcinoma from
More informationGuidelines on Neurogenic Lower Urinary Tract Dysfunction
Guidelines on Neurogenic Lower Urinary Tract Dysfunction (Text update March 2009) M. Stöhrer (chairman), B. Blok, D. Castro-Diaz, E. Chartier- Kastler, P. Denys, G. Kramer, J. Pannek, G. del Popolo, P.
More informationResearch Article Gross Hematuria in Patients with Prostate Cancer: Etiology and Management
ISRN Surgery Volume 2013, Article ID 685327, 4 pages http://dx.doi.org/10.1155/2013/685327 Research Article Gross Hematuria in Patients with Prostate Cancer: Etiology and Management Ofer N. Gofrit, 1 Ran
More informationProstatectomy as salvage therapy. Cases. Paul Cathcart - Guy s & St Thomas NHS Trust, London
Prostatectomy as salvage therapy Cases Paul Cathcart - Guy s & St Thomas NHS Trust, London Attributes of brachytherapy appeal to young men who place high utility on genitourinary function At risk of
More informationLower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist
Lower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist Lower Urinary Tract Symptoms Storage Symptoms Frequency, urgency, incontinence, Nocturia Voiding Symptoms Hesitancy, poor flow, intermittency,
More informationProstate Cancer. David Wilkinson MD Gulfshore Urology
Prostate Cancer David Wilkinson MD Gulfshore Urology What is the Prostate? Male Sexual Gland Adds nutrients and fluids for sperm This fluid is added to sperm during ejaculation Urethra (urine channel)
More informationDay 1. ICS EDUCATIONAL COURSE São Paulo 28 th - 29 th July 2006 Coordinators: Linda Cardozo & Carlos Arturo Levi D Ancona.
Day 1 AM Arrive Register 9:00-12:00 Nurses Workshop Urodynamic Course Workshop Physiotherapy Workshop 12:00 Buffet Lunch 13:00 Welcome & & Bary Berghmans & Nelson Rodrigues Netto Jr. Brazilian Urological
More informationProgramme. Day -2 5 th August 2019 Monday. Day -1 6 th August 2019 Tuesday. Day 0 7 th August 2019 Wednesday
Day -2 5 th August 2019 Monday *Disclaimer: is subject to change 08:30 Asian Urology Resident s Course (AURC) 08:30-17:00 Day -1 6 th August 2019 Tuesday 08:30 Asian Urology Resident s Course (AURC) 08:30-17:00
More informationIQSS 2019 QCDR and MIPS Measure Specifications
IQSS1 Hypogonadism: Serum T, CBC, PSA, IPSS within 6 months of Rx Percentage of patients with a Effective Clinical Patients with documented new diagnosis of hypogonadism receiving androgen replacement
More informationCHAPTER 6. M.D. Eckhardt, G.E.P.M. van Venrooij, T.A. Boon. hoofdstuk :49 Pagina 89
hoofdstuk 06 19-12-2001 09:49 Pagina 89 Urethral Resistance Factor (URA) Versus Schäfer s Obstruction Grade and Abrams-Griffiths (AG) Number in the Diagnosis of Obstructive Benign Prostatic Hyperplasia
More informationDOWNLOAD OR READ : TREATMENT OF BENIGN PROSTATIC HYPERPLASIA PDF EBOOK EPUB MOBI
DOWNLOAD OR READ : TREATMENT OF BENIGN PROSTATIC HYPERPLASIA PDF EBOOK EPUB MOBI Page 1 Page 2 treatment of benign prostatic hyperplasia treatment of benign prostatic pdf treatment of benign prostatic
More informationADENOCARCINOMA OF THE PROSTATE
Ref : ADENOCARCINOMA OF THE PROSTATE Div. of Urology, Dept. Surgery Medical Faculty, University of Sumatera Utara Clinical Manual of Urology, (Philip M. Hanno et al eds), McGraw-Hill Int ed, 3 rd ed, 2001
More informationGeneral information about prostate cancer
Prostate Cancer General information about prostate cancer Key points Prostate cancer is a disease in which malignant (cancer) cells form in the tissues of the prostate. Signs of prostate cancer include
More information